3.11 BBC: Artificial intelligence-created medicine to be used on humans for first time

In an article Artificial intelligence-created medicine to be used on humans for first time in January 2020 the BBC quoted Prof Andrew Hopkins, the CEO of Exscienta:

This year was the first to have an AI-designed drug but by the end of the decade all new drugs could potentially be created by AI
Prof Andrew Hopkins, Exscienta chief executive

The drug will be used to treat patients who have obsessive-compulsive disorder (OCD).

  • Created by
    • British start-up Exscientia
    • Japanese pharmaceutical firm Sumitomo Dainippon Pharma
  • Treat patients who have obsessive-compulsive disorder (OCD).
  • Time to get to trial
    • Typically about five years
    • AI took just 12 months.